This document is in .pdf format and can be downloaded at the bottom of this page.
In this issue:
Drug safety advice
-
Gadolinium-containing contrast agents and nephrogenic systemic fibrosis
-
Extraneal and products that contain (or are metabolised to) maltose, xylose, or galactose: false glucose reading
-
α1-adrenoreceptor antagonists and intraoperative floppy iris syndrome
-
Cabergoline: risk of cardiovalvulopathy
-
Linezolid: restriction of indication
-
Dopamine agonists and pathological gambling, increased libido, and hypersexuality
-
Antidepressants and risk of suicidal behaviour
Yellow Card scheme update
Hot topics
-
Isotretinoin for severe acne
-
Smoking-cessation aids
Stop press
- Recent letters to healthcare professionals
- Drug alerts
Other information from the MHRA
- Enforcement
- Advertising
- Consultations
Drug Safety Update: Volume 1, Issue 1, August 2007 
